These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 16503710)
1. Clostridium difficile-associated disease: an emerging threat to patient safety: insights from the Society of Infectious Diseases Pharmacists. Owens RC Pharmacotherapy; 2006 Mar; 26(3):299-311. PubMed ID: 16503710 [TBL] [Abstract][Full Text] [Related]
2. Clostridium difficile infection caused by the epidemic BI/NAP1/027 strain. O'Connor JR; Johnson S; Gerding DN Gastroenterology; 2009 May; 136(6):1913-24. PubMed ID: 19457419 [TBL] [Abstract][Full Text] [Related]
3. New trends in Clostridium difficile virulence and pathogenesis. Denève C; Janoir C; Poilane I; Fantinato C; Collignon A Int J Antimicrob Agents; 2009 Mar; 33 Suppl 1():S24-8. PubMed ID: 19303565 [TBL] [Abstract][Full Text] [Related]
4. Implications of the changing face of Clostridium difficile disease for health care practitioners. McFarland LV; Beneda HW; Clarridge JE; Raugi GJ Am J Infect Control; 2007 May; 35(4):237-53. PubMed ID: 17482995 [TBL] [Abstract][Full Text] [Related]
5. A portrait of the geographic dissemination of the Clostridium difficile North American pulsed-field type 1 strain and the epidemiology of C. difficile-associated disease in Québec. Hubert B; Loo VG; Bourgault AM; Poirier L; Dascal A; Fortin E; Dionne M; Lorange M Clin Infect Dis; 2007 Jan; 44(2):238-44. PubMed ID: 17173224 [TBL] [Abstract][Full Text] [Related]
6. Epidemiology and control of Clostridium difficile infections in healthcare settings: an update. Barbut F; Jones G; Eckert C Curr Opin Infect Dis; 2011 Aug; 24(4):370-6. PubMed ID: 21505332 [TBL] [Abstract][Full Text] [Related]
7. Emergence of Clostridium difficile-associated disease in North America and Europe. Kuijper EJ; Coignard B; Tüll P; ; ; Clin Microbiol Infect; 2006 Oct; 12 Suppl 6():2-18. PubMed ID: 16965399 [TBL] [Abstract][Full Text] [Related]
8. Update on the changing epidemiology of Clostridium difficile-associated disease. McFarland LV Nat Clin Pract Gastroenterol Hepatol; 2008 Jan; 5(1):40-8. PubMed ID: 18174906 [TBL] [Abstract][Full Text] [Related]
15. Hypervirulent strains of Clostridium difficile. Cookson B Postgrad Med J; 2007 May; 83(979):291-5. PubMed ID: 17488855 [TBL] [Abstract][Full Text] [Related]
16. Long term effect of infection control practices and associated factors during a major Clostridium difficile outbreak in Costa Rica. Wong-McClure RA; Ramírez-Salas E; Mora-Brenes N; Aguero-Sandí L; Morera-Sigler M; Badilla-Vargas X; Hernández-de Merzerville M; O'Shea M; Bryce E J Infect Dev Ctries; 2013 Dec; 7(12):914-21. PubMed ID: 24334937 [TBL] [Abstract][Full Text] [Related]
17. Identification, optimal management, and infection control measures for Clostridium difficile-associated disease in long-term care. Fletcher KR; Cinalli M Geriatr Nurs; 2007; 28(3):171-81; quiz 182. PubMed ID: 17561015 [TBL] [Abstract][Full Text] [Related]
18. Surveillance for community-associated Clostridium difficile--Connecticut, 2006. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2008 Apr; 57(13):340-3. PubMed ID: 18385641 [TBL] [Abstract][Full Text] [Related]
19. Preventing clostridium difficile infection in the intensive care unit. Zilberberg MD; Shorr AF Crit Care Clin; 2013 Jan; 29(1):11-8. PubMed ID: 23182524 [TBL] [Abstract][Full Text] [Related]